ACCRUFER

Drug Shield Therapeutics Inc
Total Payments
$1.1M
Transactions
42,637
Doctors
20,109
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $548,739 21,623 12,134
2023 $453,981 17,324 10,659
2022 $127,722 3,690 2,805

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $961,309 42,521 85.0%
Honoraria $111,713 71 9.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $31,280 9 2.8%
Travel and Lodging $26,141 36 2.3%

Top Doctors Receiving Payments for ACCRUFER — Page 805

Doctor Specialty Location Total Records
, PA Medical Orlando, FL $11.67 1
, MD Nephrology Kissimmee, FL $11.67 1
, DO, MS Family Medicine East Orange, NJ $11.67 1
, M.D Student in an Organized Health Care Education/Training Program Maricopa, AZ $11.65 1
, NP Family Mansfield, TX $11.65 1
, PA-C Physician Assistant Royal Oak, MI $11.65 1
Emily Zellmer Physician Assistant Livonia, MI $11.64 1
, FNP Family Cedar Park, TX $11.64 1
, MD Hematology & Oncology Bryan, TX $11.64 1

About ACCRUFER

ACCRUFER is a drug associated with $1.1M in payments to 20,109 healthcare providers, recorded across 42,637 transactions in the CMS Open Payments database. The primary manufacturer is Shield Therapeutics Inc.

Payment data is available from 2022 to 2024. In 2024, $548,739 was paid across 21,623 transactions to 12,134 doctors.

The most common payment nature for ACCRUFER is "Food and Beverage" ($961,309, 85.0% of total).